FDA Warning: Duloxetine Recalled Due to Nitrosamine Impurity Risks

Health authorities have issued a critical alert regarding a widely used antidepressant. The FDA has announced a significant recall of duloxetine, a generic version of the well-known medication Cymbalta, after discovering potentially harmful levels of a chemical impurity.

What is the Cause of the Recall?

The recall was initiated by Breckenridge Pharmaceutical on June 4, following the discovery of nitrosamine impurities. Nitrosamines are chemical compounds that, when present in high concentrations over a long period, may increase the risk of developing certain types of cancer.

In this specific case, nearly 360,000 bottles of duloxetine delayed-release capsules have been flagged for exceeding the acceptable safety limits of these impurities.

Which Medications are Affected?

The recall is nationwide and affects both the 30-mg and 60-mg dosage strengths. If you are currently taking duloxetine, please check your prescription bottle for the following details:

n
• 30-mg Capsules: Lot code 241180C (Expiration date: April 2027).
• 60-mg Capsules: Various lot codes and expiration dates are affected.

To verify the status of your specific medication, it is recommended to visit the official FDA website or contact your pharmacy immediately.

What Should You Do Now?

Discovering a recall on a primary medication can be alarming, but it is essential to handle the situation with caution. Follow these professional guidelines:

1. Do NOT stop your medication abruptly: Suddenly stopping an antidepressant like duloxetine can lead to severe withdrawal symptoms or a relapse of your condition.
2. Consult your healthcare provider: Contact your doctor or pharmacist immediately to discuss a safe transition to a different batch or an alternative medication.
3. Check your lot numbers: Match your bottle’s code with the recall list provided by the manufacturer.

Understanding Nitrosamine Impurities

Nitrosamines are not ingredients added to the drug intentionally. They are typically byproduct impurities that can form during the manufacturing process or through degradation. The FDA continuously monitors medications to ensure that any presence of such impurities remains well below the threshold of clinical concern.

For more information on medication safety and current recalls, stay tuned to official health bulletins and your local healthcare provider.